Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Probabilistic tsunami forecasting for early warning.

Nature communications·2021

Same author

Expression of RAD21 immunoreactivity in myenteric neurons of the human and mouse small intestine.

Neurogastroenterology and motility·2018

Same author

High temporal resolution gastric emptying breath tests in mice.

Neurogastroenterology and motility·2018

Same author

Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum.

Neurogastroenterology and motility·2017

Same author

Tumor necrosis factor alpha derived from classically activated "M1" macrophages reduces interstitial cell of Cajal numbers.

Neurogastroenterology and motility·2016

Same author

Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis.

Neurogastroenterology and motility·2016

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Cellular pathogenesis of diabetic gastroenteropathy.

T Ordög¹, Y Hayashi, S J Gibbons

¹Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA. ordog.tamas@mayo.edu

Minerva Gastroenterologica E Dietologica

|October 16, 2009

Summary

Diabetic gastroenteropathies involve multifactorial cellular changes affecting gut motility, not a single defect. Understanding these neuromuscular dystrophies is key to developing effective diabetes mellitus treatments.

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Area of Science:

Gastroenterology
Diabetology
Neuromuscular Disorders

Background:

Diabetic gastroenteropathy is common in diabetes mellitus, causing significant symptoms and healthcare burdens.
Current treatments for diabetic gastroenteropathy are primarily symptomatic and often ineffective.
A deeper understanding of the cellular and molecular pathogenesis is needed for improved therapies.

Purpose of the Study:

To review the cellular changes and potential causes of diabetic gastroenteropathies.
To focus on the functional interactions between different cell types involved in gastrointestinal motility.
To propose a new perspective on diabetic gastroenteropathies as a form of gastrointestinal neuromuscular dystrophy.

Main Methods:

Review of recent advances in understanding gastrointestinal motility control systems.
Utilization of new experimental models.
Application of sophisticated physiological, morphological, and molecular techniques.

Main Results:

Diabetic gastroenteropathies result from multifactorial metabolic and dystrophic changes affecting the autonomic nervous system, enteric nervous system, interstitial cells of Cajal, and smooth muscle cells.
Candidate pathomechanisms include oxidative stress imbalance, altered trophic stimuli, and potential autoimmune factors.
These disorders are complex and involve a spectrum of cellular dysfunctions rather than a singular defect.

Conclusions:

Diabetic gastroenteropathies should be viewed as a gastrointestinal neuromuscular dystrophy, not merely a functional disorder.
Future research should focus on blocking cytotoxic factors and supporting cellular regeneration.
Translating experimental findings into novel treatment strategies is crucial for managing diabetic gastroenteropathies.